New Journey Health Technology Group Co.,LTD (SHE:002219)
China
· Delayed Price · Currency is CNY 2.490
-0.010 (-0.40%)
Mar 10, 2026, 11:34 AM CST
SHE:002219 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 8,444 | 8,916 | 10,335 | 12,861 | 6,827 | 3,301 | Upgrade
|
| Market Cap Growth | -6.02% | -13.72% | -19.64% | 88.39% | 106.78% | -25.94% | Upgrade
|
| Enterprise Value | 9,691 | 10,339 | 11,320 | 12,997 | 8,228 | 4,854 | Upgrade
|
| Last Close Price | 2.50 | 2.64 | 3.03 | 3.94 | 3.66 | 1.77 | Upgrade
|
| PE Ratio | 431.22 | 77.69 | 356.71 | 82.38 | - | - | Upgrade
|
| Forward PE | - | 59.75 | 59.75 | 59.75 | 59.75 | 59.75 | Upgrade
|
| PS Ratio | 2.72 | 2.35 | 2.64 | 4.07 | 2.26 | 1.18 | Upgrade
|
| PB Ratio | 4.17 | 4.37 | 4.76 | 7.28 | 4.30 | 20.92 | Upgrade
|
| P/TBV Ratio | 18.32 | 19.10 | 17.58 | 22.43 | 17.17 | - | Upgrade
|
| P/FCF Ratio | 91.83 | 68.03 | 92.90 | 276.78 | 86.89 | 49.11 | Upgrade
|
| P/OCF Ratio | 22.95 | 20.33 | 32.20 | 47.98 | 24.62 | 11.63 | Upgrade
|
| PEG Ratio | - | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 | Upgrade
|
| EV/Sales Ratio | 3.12 | 2.72 | 2.89 | 4.11 | 2.73 | 1.73 | Upgrade
|
| EV/EBITDA Ratio | 24.88 | 22.14 | 29.43 | 33.68 | 64.65 | 13.87 | Upgrade
|
| EV/EBIT Ratio | 43.43 | 33.65 | 64.00 | 56.53 | - | 27.08 | Upgrade
|
| EV/FCF Ratio | 105.39 | 78.88 | 101.75 | 279.72 | 104.73 | 72.21 | Upgrade
|
| Debt / Equity Ratio | 0.75 | 0.97 | 1.11 | 0.73 | 1.23 | 11.27 | Upgrade
|
| Debt / EBITDA Ratio | 3.87 | 3.87 | 5.79 | 3.25 | 15.29 | 5.08 | Upgrade
|
| Debt / FCF Ratio | 16.38 | 15.04 | 21.61 | 27.72 | 24.86 | 26.46 | Upgrade
|
| Net Debt / Equity Ratio | 0.59 | 0.73 | 0.83 | 0.41 | -0.05 | 10.18 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.44 | 3.20 | 4.69 | 1.89 | -0.63 | 4.59 | Upgrade
|
| Net Debt / FCF Ratio | 12.97 | 11.39 | 16.20 | 15.68 | -1.02 | 23.91 | Upgrade
|
| Asset Turnover | 0.49 | 0.57 | 0.64 | 0.51 | 0.52 | 0.58 | Upgrade
|
| Inventory Turnover | 10.73 | 12.20 | 13.92 | 12.34 | 12.15 | 12.10 | Upgrade
|
| Quick Ratio | 0.49 | 0.50 | 0.52 | 0.44 | 0.60 | 0.23 | Upgrade
|
| Current Ratio | 0.56 | 0.57 | 0.59 | 0.54 | 0.66 | 0.29 | Upgrade
|
| Return on Equity (ROE) | 0.77% | 5.71% | 2.02% | 9.84% | -42.13% | -23.27% | Upgrade
|
| Return on Assets (ROA) | 2.19% | 2.89% | 1.80% | 2.33% | -0.39% | 2.30% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.51% | 6.38% | 5.47% | 10.11% | -2.17% | -39.62% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.10% | 9.80% | 5.60% | 9.90% | -1.70% | 24.50% | Upgrade
|
| Earnings Yield | 0.23% | 1.29% | 0.28% | 1.21% | -5.44% | -1.58% | Upgrade
|
| FCF Yield | 1.09% | 1.47% | 1.08% | 0.36% | 1.15% | 2.04% | Upgrade
|
| Payout Ratio | 546.20% | 103.03% | 366.45% | 176.67% | - | - | Upgrade
|
| Buyback Yield / Dilution | 1.65% | -1.02% | 0.33% | -75.08% | 0.02% | 0.03% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.